Anti-Cub Domain-Containing Protein 1 (CDCP1) Antibodies, Antibody Drug Conjugates, and Methods of Use Thereof
Copyright © Targeted News Service 2024
2024-11-12
ALEXANDRIA, Virginia, Nov. 12 -- BLUEFIN BIOMEDICINE, INC., Beverly, Massachusetts has been assigned a patent (No. US 12138314 B2, initially filed March 21, 2024) developed by six inventors Hong Ren, Brighton, Massachusetts; Scott Michael Lonning, Westford, Massachusetts; Nels Eric Pederson, Mansfield, Massachusetts; Klarisa Rikova, Reading, Massachusetts; Aleksandr Tkachev, Cambridge, Massachusetts; and Tinglei Gu, Andover, Massachusetts, for "Anti-CUB domain-containing protein 1 (CDCP1) antib . . .